{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-154062","form_type":"8-K","ticker":"NKTR","cik":"0000906709","company_name":"NEKTAR THERAPEUTICS","filed_at":"2025-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.655124+00:00","generated_at":"2026-05-18T11:45:31.180342+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Nektar Therapeutics prices $100M public offering at $23.50 per share","bullets":["Nektar prices 4,255,320 shares at $23.50/share for gross proceeds of $100M.","Net proceeds estimated at $93.7M ($107.8M if underwriters' option exercised in full).","Offering expected to close July 2, 2025; Jefferies and Piper Sandler are joint bookrunners.","Proceeds to fund R&D, clinical development, manufacturing, and other general corporate purposes.","Underwriters have a 30-day option to purchase up to an additional 638,298 shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-154062","json":"https://secwatch.observer/filing/0001193125-25-154062.json","markdown":"https://secwatch.observer/filing/0001193125-25-154062.md","text":"https://secwatch.observer/filing/0001193125-25-154062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/906709/000119312525154062/0001193125-25-154062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/906709/000119312525154062/d943939d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T11:45:31.180342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}